Gratus Wealth Advisors LLC Purchases New Position in Astrazeneca Plc $AZN
Gratus Wealth Advisors LLC acquired a new stake in Astrazeneca Plc (NYSE:AZN – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 5,407 shares of the company’s stock, valued at approximately $949,000. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Trek Financial LLC raised […]
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.